Biotest AG (Biotest AG) Total Liabilities : $998.8 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Total Liabilities?

Biotest AG's Total Liabilities for the quarter that ended in Mar. 2024 was $998.8 Mil.

Biotest AG's quarterly Total Liabilities increased from Sep. 2023 ($949.41 Mil) to Dec. 2023 ($994.55 Mil) and increased from Dec. 2023 ($994.55 Mil) to Mar. 2024 ($998.80 Mil).

Biotest AG's annual Total Liabilities increased from Dec. 2021 ($817.85 Mil) to Dec. 2022 ($881.25 Mil) and increased from Dec. 2022 ($881.25 Mil) to Dec. 2023 ($994.55 Mil).

Biotest AG Total Liabilities Historical Data

The historical data trend for Biotest AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Total Liabilities Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

701.67

839.05

817.85

881.25

994.55

Biotest AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															898.39	910.73	949.41	994.55	998.80

Biotest AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biotest AG's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	420.174	+	(416.467	+	58.233
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	99.673)
	=	994.5

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1538.604	-	544.057
	=	994.5

Biotest AG's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	425.217	+	(0	+	472.826
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	100.761)
	=	998.8

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1572.609	-	573.804
	=	998.8

Biotest AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biotest AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG (Biotest AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BIO3:Germany BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.